Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 16;14(18):4489.
doi: 10.3390/cancers14184489.

Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS

Affiliations

Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS

Dorota Słowińska-Klencka et al. Cancers (Basel). .

Abstract

The aim of the study was to examine the benefits of the joint use of repeat FNA (rFNA) and EU-TIRADS in category III nodules in relation to the kind of atypia: nuclear vs. architectural (denoted by AUS and FLUS respectively). The study included 127 AUS and 1739 FLUS nodules with a known category of EU-TIRADS. Repeat FNA was performed in 82 AUS and 934 FLUS nodules of which 57 and 515 were excised, respectively. AUS nodules had higher malignancy risk than FLUS nodules. EU-TIRADS showed higher accuracy for AUS nodules, the opposite to rFNA, that had higher accuracy for FLUS nodules. The combined criterion for AUS nodules (at least rFNA-V or EU-TIRADS-4) maximized sensitivity (92.3%) with acceptable specificity (70.0%); OR: 28.0. In the case of FLUS nodules, the combined criterion (rFNA-V or EU-TIRADS-5) maximized specificity (95.2%) with 57.7% sensitivity and a low percentage (13.9%) of positive nodules, OR: 27.0. In both types of nodules, the low risk category in EU-TIRADS and benign result of rFNA excluded cancer. Concluding, category III nodules with and without nuclear atypia differ in their risk of malignancy and, consequently, diagnostic criteria adopted for the evaluation of these nodules with rFNA and EU-TIRADS should be specific to AUS and FLUS nodules.

Keywords: AUS; Bethesda system; EU-TIRADS; FLUS; FNA; architectural atypia; cancer; nuclear atypia; thyroid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Similar articles

Cited by

References

    1. Cibas E.S., Ali S.Z. NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology. Am. J. Clin. Pathol. 2009;132:658–665. doi: 10.1309/AJCPPHLWMI3JV4LA. - DOI - PubMed
    1. Cibas E.S., Ali S.Z. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27:1341–1346. doi: 10.1089/thy.2017.0500. - DOI - PubMed
    1. Vuong H.G., Ngo H.T.T., Bychkov A., Jung C.K., Vu T.H., Lu K.B., Kakudo K., Kondo T. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis. Cancer Cytopathol. 2020;128:238–249. doi: 10.1002/cncy.22228. - DOI - PubMed
    1. Nishino M., Wang H.H. Should the thyroid AUS/FLUS category be further stratified by malignancy risk? Cancer Cytopathol. 2014;122:481–483. doi: 10.1002/cncy.21412. - DOI - PubMed
    1. Eisa N., Khan A., Akhter M., Fensterwald M., Saleem S., Fananapazir G., Campbell M.J. Both ultrasound features and nuclear atypia are associated with malignancy in thyroid nodules with atypia of undetermined significance. Ann. Surg. Oncol. 2018;25:3913–3918. doi: 10.1245/s10434-018-6826-6. - DOI - PubMed

LinkOut - more resources